An integrated single-cell and spatial transcriptomic atlas of thyroid cancer progression identifies prognostic fibroblast subpopulations

Matthew A. Loberg(Jackson Laboratory), Vivian Weiß(Vanderbilt University Medical Center), Carmen C. Solórzano(Vanderbilt University Medical Center), Jennifer H. Choe(Vanderbilt University Medical Center), Eric C. Huang(Oregon Health & Science University), James L. Netterville(Breast Cancer Research Foundation), Reilly G. Fankhauser(Vanderbilt University Medical Center), Sarah L. Rohde(Vanderbilt University Medical Center), Quanhu Sheng(Cancer Research And Biostatistics), Megan L. Tigue(Vanderbilt University Medical Center), Maxime Tarabichi(University of Toronto), Jennifer Wang(The University of Texas MD Anderson Cancer Center), Heather A. Hartmann(Vanderbilt University Medical Center), Elizabeth M. Jaffee(Bloomberg (United States)), Courtney J. Phifer(Vanderbilt University Medical Center), Dayle K. Wang(Vanderbilt University Medical Center), Hua‐Chang Chen(Vanderbilt University Medical Center), Sheau‐Chiann Chen(Vanderbilt University Medical Center), Ken S. Lau(Vanderbilt University), George Xu(Brigham and Women's Hospital), Sophia M. Shaddy(University of Washington), Ryan H. Belcher(Monroe Carell Jr. Children's Hospital), Luciane T. Kagohara(Bloomberg (United States)), Jean‐Nicolas Gallant(Pediatrics and Genetics), Ethan Lee(Johns Hopkins University), Claudia C. Wahoski(Vanderbilt University Medical Center), Kailey Caroland(University of Maryland, Baltimore), Fei Ye(University of Miami), Lindsay Bischoff(Breast Cancer Research Foundation), Naira Baregamian(Vanderbilt University Medical Center), Barbara A. Murphy(Vanderbilt University Medical Center), Chia-Chin Wu(The University of Texas MD Anderson Cancer Center)
bioRxiv (Cold Spring Harbor Laboratory)
January 9, 2025
Cited by 6


Related Papers